Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
出版年份 2021 全文链接
标题
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-05-17
DOI
10.3389/fcimb.2021.684515
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- It's Time to Reverse our Thinking: The Reverse Translation Research Paradigm
- (2018) Valentina Shakhnovich CTS-Clinical and Translational Science
- Antibiotic–non-antibiotic combinations for combating extremely drug-resistant Gram-negative ‘superbugs’
- (2017) Elena K. Schneider et al. Essays in Biochemistry
- The antibiotic pipeline: reviving research and development and speeding drugs to market
- (2017) Katherine H. Luepke et al. Expert Review of Anti-Infective Therapy
- The FDA’s Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016
- (2017) Thomas J. Hwang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
- (2017) Victoria L Simpkin et al. JOURNAL OF ANTIBIOTICS
- The antibiotic resistance crisis, with a focus on the United States
- (2017) Evan Martens et al. JOURNAL OF ANTIBIOTICS
- Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus
- (2017) Saskia Zimmermann et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Opportunities and challenges in phenotypic drug discovery: an industry perspective
- (2017) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
- (2017) Sana R Mostaghim et al. BMJ-British Medical Journal
- Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
- (2017) Sana R Mostaghim et al. BMJ-British Medical Journal
- Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery
- (2017) William D. Fiers et al. ACS Infectious Diseases
- Antibiotic Resistance: A Public Health Crisis
- (2017) Boris D. Lushniak PUBLIC HEALTH REPORTS
- Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
- (2016) Michael S. Sinha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening
- (2016) Leigh M. Matano et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance: Table 1.
- (2016) Kimberly Sciarretta et al. CLINICAL INFECTIOUS DISEASES
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Natural product discovery: past, present, and future
- (2016) Leonard Katz et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs
- (2016) Chul Kim et al. MAYO CLINIC PROCEEDINGS
- Antibacterial drug discovery in the resistance era
- (2016) Eric D. Brown et al. NATURE
- Parsing clinical success rates
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- Natural Products as a Source for Novel Antibiotics
- (2016) Mark G. Moloney TRENDS IN PHARMACOLOGICAL SCIENCES
- Endless resistance. Endless antibiotics?
- (2016) Jed F. Fisher et al. MedChemComm
- A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
- (2016) David M. Brogan et al. Globalization and Health
- A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase
- (2016) Shilah A. Bonnett et al. ACS Infectious Diseases
- Unconventional screening approaches for antibiotic discovery
- (2015) Maya A. Farha et al. Annals of the New York Academy of Sciences
- Repurposing metformin: an old drug with new tricks in its binding pockets
- (2015) R. Pryor et al. BIOCHEMICAL JOURNAL
- Thalidomide-induced teratogenesis: History and mechanisms
- (2015) Neil Vargesson BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Antibacterial Drug Discovery: Doing It Right
- (2015) Martin Gengenbacher et al. CHEMISTRY & BIOLOGY
- Drug Repurposing for the Treatment of Staphylococcal Infections
- (2015) Shankar Thangamani et al. CURRENT PHARMACEUTICAL DESIGN
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- The resurgence of phenotypic screening in drug discovery and development
- (2015) Bridget K. Wagner Expert Opinion on Drug Discovery
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
- (2015) David Brown NATURE REVIEWS DRUG DISCOVERY
- The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development
- (2015) Emma Heslop et al. Orphanet Journal of Rare Diseases
- Incentives to Repurpose Existing Drugs for Orphan Indications
- (2015) Annette K. Kwok et al. ACS Medicinal Chemistry Letters
- The FDA’s new clothes
- (2015) Donald W Light et al. BMJ-British Medical Journal
- Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
- (2015) Aaron S Kesselheim et al. BMJ-British Medical Journal
- The FDA’s new clothes
- (2015) Donald W Light et al. BMJ-British Medical Journal
- Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
- (2015) Aaron S Kesselheim et al. BMJ-British Medical Journal
- FDA Designations for Therapeutics and Their Impact on Drug Development and Regulatory Review Outcomes
- (2015) AS Kesselheim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model
- (2015) Michael Stenger et al. PLoS One
- Something old, something new: revisiting natural products in antibiotic drug discovery
- (2014) Gerard D. Wright CANADIAN JOURNAL OF MICROBIOLOGY
- Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens
- (2014) Erin E. Gill et al. Chemical Biology & Drug Design
- Update on the antibiotic resistance crisis
- (2014) Gian Maria Rossolini et al. CURRENT OPINION IN PHARMACOLOGY
- Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals
- (2014) Cassie Frank et al. HEALTH AFFAIRS
- Repurposing the Antihistamine Terfenadine for Antimicrobial Activity against Staphylococcus aureus
- (2014) Jessamyn I. Perlmutter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks
- (2014) Stephen M Strittmatter NATURE MEDICINE
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- New FDA Breakthrough-Drug Category — Implications for Patients
- (2014) Jonathan J. Darrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Debate erupts on 'repurposed' drugs for Ebola
- (2014) M. Enserink SCIENCE
- Selective Chemical Inhibition of agr Quorum Sensing in Staphylococcus aureus Promotes Host Defense with Minimal Impact on Resistance
- (2014) Erin K. Sully et al. PLoS Pathogens
- Pharmaceutical R&D Performance by Firm Size
- (2013) Joseph A. DiMasi AMERICAN JOURNAL OF THERAPEUTICS
- Disruption of Biofilm Formation by the Human Pathogen Acinetobacter baumannii Using Engineered Quorum-Quenching Lactonases
- (2013) Jeng Yeong Chow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is the GAIN Act a turning point in new antibiotic discovery?
- (2013) Eric D. Brown CANADIAN JOURNAL OF MICROBIOLOGY
- Innovating by Developing New Uses of Already-Approved Drugs: Trends in the Marketing Approval of Supplemental Indications
- (2013) Joseph A. DiMasi CLINICAL THERAPEUTICS
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- Phenotypic screens as a renewed approach for drug discovery
- (2013) Wei Zheng et al. DRUG DISCOVERY TODAY
- Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
- (2013) Guangxu Jin et al. DRUG DISCOVERY TODAY
- Prospects for new antibiotics: a molecule-centered perspective
- (2013) Christopher T Walsh et al. JOURNAL OF ANTIBIOTICS
- A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
- (2013) John H Rex et al. LANCET INFECTIOUS DISEASES
- Platforms for antibiotic discovery
- (2013) Kim Lewis NATURE REVIEWS DRUG DISCOVERY
- Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
- (2013) Kimberly M. Carlson-Banning et al. PLoS One
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Antibiotic adjuvants: identification and clinical use
- (2013) Patricia Bernal et al. Microbial Biotechnology
- A Whole-Cell Phenotypic Screening Platform for Identifying Methylerythritol Phosphate Pathway-Selective Inhibitors as Novel Antibacterial Agents
- (2012) Charles A. Testa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Orphan Drugs for Rare Diseases
- (2012) Steven Simoens et al. DRUGS
- NCATS launches drug repurposing program
- (2012) Malorye Allison NATURE BIOTECHNOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Penicillin: the medicine with the greatest impact on therapeutic outcomes
- (2011) Nelson Kardos et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Drug repositioning for orphan diseases
- (2011) D. Sardana et al. BRIEFINGS IN BIOINFORMATICS
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Resistance drives antibacterial drug development
- (2011) Ursula Theuretzbacher CURRENT OPINION IN PHARMACOLOGY
- Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups
- (2011) David Cavalla et al. DRUG DISCOVERY TODAY
- Antibiotic adjuvants: multicomponent anti-infective strategies
- (2011) Lindsay Kalan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Discovery research: the scientific challenge of finding new antibiotics
- (2011) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug repositioning: Re-investigating existing drugs for new therapeutic indications
- (2011) BM Padhy et al. Journal of Postgraduate Medicine
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Use of Ichip for High-Throughput In Situ Cultivation of "Uncultivable" Microbial Species
- (2010) D. Nichols et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future
- (2010) K. Mazumdar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The continuing crisis in antibiotic resistance
- (2010) G.L. French INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
- (2009) Samuel Broder ANTIVIRAL RESEARCH
- Antibiotics for Emerging Pathogens
- (2009) M. A. Fischbach et al. SCIENCE
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide
- (2008) I. Couto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search